Antitumor activity, safety and predictive biomarker results of ENMD-2076 administered to patients with recurrent ovarian clear cell carcinoma (OCCC): A trial of the Princess Margaret Phase II Consortium Victor Rodriguez- - The Princess - Document - PDFSEARCH.IO

First Page	Meta Content
	Antitumor activity, safety and predictive biomarker results of ENMD-2076 administered to patients with recurrent ovarian clear cell carcinoma (OCCC): A trial of the Princess Margaret Phase II Consortium Victor Rodriguez- Add to Reading List Document Date: 2016-06-08 13:14:14 Open Document File Size: 2,96 MB Share Result on Facebook

Antitumor activity, safety and predictive biomarker results of ENMD-2076 administered to patients with recurrent ovarian clear cell carcinoma (OCCC): A trial of the Princess Margaret Phase II Consortium Victor Rodriguez-Add to Reading List